Loading…
Fabrication of a biodegradable drug delivery system with controlled release made of PLGA 5-FU hydroxyapatite
Purpose - Rapid prototyping (RP) technology has been widely applied in biomedical research. The purpose of this paper is to describe how a scaffold composite drug delivery system (DDS) was fabricated using a nano composite deposition system (NCDS).Design methodology approach - A biocompatible and bi...
Saved in:
Published in: | Rapid prototyping journal 2008-01, Vol.14 (5), p.293-299 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c450t-d50d41023abfac305afe8a070e97069526d60bff6ece9dc6c1e215697ed18e293 |
---|---|
cites | cdi_FETCH-LOGICAL-c450t-d50d41023abfac305afe8a070e97069526d60bff6ece9dc6c1e215697ed18e293 |
container_end_page | 299 |
container_issue | 5 |
container_start_page | 293 |
container_title | Rapid prototyping journal |
container_volume | 14 |
creator | Chu, Won-Shik Jeong, Suk-Young Kim, Sung-Geun Ha, Won-Shik Chi, Sang-Chul Ahn, Sung-Hoon |
description | Purpose - Rapid prototyping (RP) technology has been widely applied in biomedical research. The purpose of this paper is to describe how a scaffold composite drug delivery system (DDS) was fabricated using a nano composite deposition system (NCDS).Design methodology approach - A biocompatible and biodegradable thermoplastic polymer (poly(DL-lactide-co-glycolide acid)) was used as the matrix, and a mixture of anti-cancer drug (5-fluorouracil) and bio-ceramic (hydroxyapatite - HA) was added to the polymer to form a bio-composite material for the DDS. An in vitro drug release test showed that the release rate of the drug composite could be controlled by the amount of HA for 50 days.Findings - Faster release was observed for the DDS with higher weight percent of HA. The relationship between release rate and the amount of HA showed a bi-linear manner, and bi-linear drug release models were developed based on the experimental results.Originality value - Cylindrical scaffolds were fabricated with polymer drug additive using an NCDS. A series of in vitro drug release tests was performed to evaluate the effectiveness of the additive, HA. Drug release models were developed based on the experimental results. |
doi_str_mv | 10.1108/13552540810907965 |
format | article |
fullrecord | <record><control><sourceid>proquest_emera</sourceid><recordid>TN_cdi_proquest_journals_2439157041</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2439157041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-d50d41023abfac305afe8a070e97069526d60bff6ece9dc6c1e215697ed18e293</originalsourceid><addsrcrecordid>eNp10V1L7DAQBuAiCn7-AO-CB7yyOtPmo70UOavCgl7odUmTqVbSzZ6k67H_3iwrCMpeZSDPOzMwWXaKcIkI1RWWQhSCQ4VQg6ql2MkOUIkqV1LBbqrTf56A3M8OY3wDwIILOMjcTLehN3rs_YL5jmnW9t7SS9BWt46YDasXZsn17xQmFqc40sD-9-MrM34xBu8cWRbIkY7EBm1p3eRxfnvNRD57Zq-TDf5j0ss0YKTjbK_TLtLJ13uUPc_-Pt3c5fOH2_ub63lu0k5jbgVYjlCUuu20KUHojioNCqhWIGtRSCuh7TpJhmprpEEqUMhakcWKiro8ys43fZfB_1tRHJuhj4ac0wvyq9gUwLmSpUjwzw_45ldhkXZrCl7WKBRwTOpsq0IOCLxaI9wgE3yMgbpmGfpBh6lBaNYnan6dKGUuNhkaKGhnvyM_abO0XeKwhW-d8AkYBJ5W</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214010481</pqid></control><display><type>article</type><title>Fabrication of a biodegradable drug delivery system with controlled release made of PLGA 5-FU hydroxyapatite</title><source>ABI/INFORM Global</source><source>Emerald:Jisc Collections:Emerald Subject Collections HE and FE 2024-2026:Emerald Premier (reading list)</source><creator>Chu, Won-Shik ; Jeong, Suk-Young ; Kim, Sung-Geun ; Ha, Won-Shik ; Chi, Sang-Chul ; Ahn, Sung-Hoon</creator><creatorcontrib>Chu, Won-Shik ; Jeong, Suk-Young ; Kim, Sung-Geun ; Ha, Won-Shik ; Chi, Sang-Chul ; Ahn, Sung-Hoon</creatorcontrib><description>Purpose - Rapid prototyping (RP) technology has been widely applied in biomedical research. The purpose of this paper is to describe how a scaffold composite drug delivery system (DDS) was fabricated using a nano composite deposition system (NCDS).Design methodology approach - A biocompatible and biodegradable thermoplastic polymer (poly(DL-lactide-co-glycolide acid)) was used as the matrix, and a mixture of anti-cancer drug (5-fluorouracil) and bio-ceramic (hydroxyapatite - HA) was added to the polymer to form a bio-composite material for the DDS. An in vitro drug release test showed that the release rate of the drug composite could be controlled by the amount of HA for 50 days.Findings - Faster release was observed for the DDS with higher weight percent of HA. The relationship between release rate and the amount of HA showed a bi-linear manner, and bi-linear drug release models were developed based on the experimental results.Originality value - Cylindrical scaffolds were fabricated with polymer drug additive using an NCDS. A series of in vitro drug release tests was performed to evaluate the effectiveness of the additive, HA. Drug release models were developed based on the experimental results.</description><identifier>ISSN: 1355-2546</identifier><identifier>EISSN: 1758-7670</identifier><identifier>DOI: 10.1108/13552540810907965</identifier><identifier>CODEN: RPJOFC</identifier><language>eng</language><publisher>Bradford: Emerald Group Publishing Limited</publisher><subject>Additives ; Biocompatibility ; Biodegradability ; Biodegradable materials ; Biomedical materials ; Biomedical research ; Composite materials ; Controlled release ; Drug delivery systems ; Drugs ; Electron microscopes ; Experiments ; Hydroxyapatite ; In vitro methods and tests ; Performance evaluation ; Permeability ; Polylactic acid ; Polymer matrix composites ; Polymers ; Pore size ; Product development ; Rapid prototyping ; Scaffolds ; Studies</subject><ispartof>Rapid prototyping journal, 2008-01, Vol.14 (5), p.293-299</ispartof><rights>Emerald Group Publishing Limited</rights><rights>Copyright Emerald Group Publishing Limited 2008</rights><rights>Emerald Group Publishing Limited 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-d50d41023abfac305afe8a070e97069526d60bff6ece9dc6c1e215697ed18e293</citedby><cites>FETCH-LOGICAL-c450t-d50d41023abfac305afe8a070e97069526d60bff6ece9dc6c1e215697ed18e293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/214010481?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,11688,27924,27925,36060,36061,44363</link.rule.ids></links><search><creatorcontrib>Chu, Won-Shik</creatorcontrib><creatorcontrib>Jeong, Suk-Young</creatorcontrib><creatorcontrib>Kim, Sung-Geun</creatorcontrib><creatorcontrib>Ha, Won-Shik</creatorcontrib><creatorcontrib>Chi, Sang-Chul</creatorcontrib><creatorcontrib>Ahn, Sung-Hoon</creatorcontrib><title>Fabrication of a biodegradable drug delivery system with controlled release made of PLGA 5-FU hydroxyapatite</title><title>Rapid prototyping journal</title><description>Purpose - Rapid prototyping (RP) technology has been widely applied in biomedical research. The purpose of this paper is to describe how a scaffold composite drug delivery system (DDS) was fabricated using a nano composite deposition system (NCDS).Design methodology approach - A biocompatible and biodegradable thermoplastic polymer (poly(DL-lactide-co-glycolide acid)) was used as the matrix, and a mixture of anti-cancer drug (5-fluorouracil) and bio-ceramic (hydroxyapatite - HA) was added to the polymer to form a bio-composite material for the DDS. An in vitro drug release test showed that the release rate of the drug composite could be controlled by the amount of HA for 50 days.Findings - Faster release was observed for the DDS with higher weight percent of HA. The relationship between release rate and the amount of HA showed a bi-linear manner, and bi-linear drug release models were developed based on the experimental results.Originality value - Cylindrical scaffolds were fabricated with polymer drug additive using an NCDS. A series of in vitro drug release tests was performed to evaluate the effectiveness of the additive, HA. Drug release models were developed based on the experimental results.</description><subject>Additives</subject><subject>Biocompatibility</subject><subject>Biodegradability</subject><subject>Biodegradable materials</subject><subject>Biomedical materials</subject><subject>Biomedical research</subject><subject>Composite materials</subject><subject>Controlled release</subject><subject>Drug delivery systems</subject><subject>Drugs</subject><subject>Electron microscopes</subject><subject>Experiments</subject><subject>Hydroxyapatite</subject><subject>In vitro methods and tests</subject><subject>Performance evaluation</subject><subject>Permeability</subject><subject>Polylactic acid</subject><subject>Polymer matrix composites</subject><subject>Polymers</subject><subject>Pore size</subject><subject>Product development</subject><subject>Rapid prototyping</subject><subject>Scaffolds</subject><subject>Studies</subject><issn>1355-2546</issn><issn>1758-7670</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>M0C</sourceid><recordid>eNp10V1L7DAQBuAiCn7-AO-CB7yyOtPmo70UOavCgl7odUmTqVbSzZ6k67H_3iwrCMpeZSDPOzMwWXaKcIkI1RWWQhSCQ4VQg6ql2MkOUIkqV1LBbqrTf56A3M8OY3wDwIILOMjcTLehN3rs_YL5jmnW9t7SS9BWt46YDasXZsn17xQmFqc40sD-9-MrM34xBu8cWRbIkY7EBm1p3eRxfnvNRD57Zq-TDf5j0ss0YKTjbK_TLtLJ13uUPc_-Pt3c5fOH2_ub63lu0k5jbgVYjlCUuu20KUHojioNCqhWIGtRSCuh7TpJhmprpEEqUMhakcWKiro8ys43fZfB_1tRHJuhj4ac0wvyq9gUwLmSpUjwzw_45ldhkXZrCl7WKBRwTOpsq0IOCLxaI9wgE3yMgbpmGfpBh6lBaNYnan6dKGUuNhkaKGhnvyM_abO0XeKwhW-d8AkYBJ5W</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Chu, Won-Shik</creator><creator>Jeong, Suk-Young</creator><creator>Kim, Sung-Geun</creator><creator>Ha, Won-Shik</creator><creator>Chi, Sang-Chul</creator><creator>Ahn, Sung-Hoon</creator><general>Emerald Group Publishing Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0U~</scope><scope>1-H</scope><scope>7TB</scope><scope>7WY</scope><scope>7WZ</scope><scope>7XB</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>ABJCF</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>F~G</scope><scope>HCIFZ</scope><scope>K6~</scope><scope>L.-</scope><scope>L.0</scope><scope>L6V</scope><scope>M0C</scope><scope>M7S</scope><scope>PQBIZ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>Q9U</scope><scope>S0W</scope><scope>PRINS</scope><scope>7QO</scope><scope>P64</scope></search><sort><creationdate>20080101</creationdate><title>Fabrication of a biodegradable drug delivery system with controlled release made of PLGA 5-FU hydroxyapatite</title><author>Chu, Won-Shik ; Jeong, Suk-Young ; Kim, Sung-Geun ; Ha, Won-Shik ; Chi, Sang-Chul ; Ahn, Sung-Hoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-d50d41023abfac305afe8a070e97069526d60bff6ece9dc6c1e215697ed18e293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Additives</topic><topic>Biocompatibility</topic><topic>Biodegradability</topic><topic>Biodegradable materials</topic><topic>Biomedical materials</topic><topic>Biomedical research</topic><topic>Composite materials</topic><topic>Controlled release</topic><topic>Drug delivery systems</topic><topic>Drugs</topic><topic>Electron microscopes</topic><topic>Experiments</topic><topic>Hydroxyapatite</topic><topic>In vitro methods and tests</topic><topic>Performance evaluation</topic><topic>Permeability</topic><topic>Polylactic acid</topic><topic>Polymer matrix composites</topic><topic>Polymers</topic><topic>Pore size</topic><topic>Product development</topic><topic>Rapid prototyping</topic><topic>Scaffolds</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chu, Won-Shik</creatorcontrib><creatorcontrib>Jeong, Suk-Young</creatorcontrib><creatorcontrib>Kim, Sung-Geun</creatorcontrib><creatorcontrib>Ha, Won-Shik</creatorcontrib><creatorcontrib>Chi, Sang-Chul</creatorcontrib><creatorcontrib>Ahn, Sung-Hoon</creatorcontrib><collection>CrossRef</collection><collection>Global News & ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest Business Premium Collection</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ProQuest Engineering Collection</collection><collection>ABI/INFORM Global</collection><collection>Engineering Database</collection><collection>One Business</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>ProQuest Central Basic</collection><collection>DELNET Engineering & Technology Collection</collection><collection>ProQuest Central China</collection><collection>Biotechnology Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Rapid prototyping journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chu, Won-Shik</au><au>Jeong, Suk-Young</au><au>Kim, Sung-Geun</au><au>Ha, Won-Shik</au><au>Chi, Sang-Chul</au><au>Ahn, Sung-Hoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fabrication of a biodegradable drug delivery system with controlled release made of PLGA 5-FU hydroxyapatite</atitle><jtitle>Rapid prototyping journal</jtitle><date>2008-01-01</date><risdate>2008</risdate><volume>14</volume><issue>5</issue><spage>293</spage><epage>299</epage><pages>293-299</pages><issn>1355-2546</issn><eissn>1758-7670</eissn><coden>RPJOFC</coden><abstract>Purpose - Rapid prototyping (RP) technology has been widely applied in biomedical research. The purpose of this paper is to describe how a scaffold composite drug delivery system (DDS) was fabricated using a nano composite deposition system (NCDS).Design methodology approach - A biocompatible and biodegradable thermoplastic polymer (poly(DL-lactide-co-glycolide acid)) was used as the matrix, and a mixture of anti-cancer drug (5-fluorouracil) and bio-ceramic (hydroxyapatite - HA) was added to the polymer to form a bio-composite material for the DDS. An in vitro drug release test showed that the release rate of the drug composite could be controlled by the amount of HA for 50 days.Findings - Faster release was observed for the DDS with higher weight percent of HA. The relationship between release rate and the amount of HA showed a bi-linear manner, and bi-linear drug release models were developed based on the experimental results.Originality value - Cylindrical scaffolds were fabricated with polymer drug additive using an NCDS. A series of in vitro drug release tests was performed to evaluate the effectiveness of the additive, HA. Drug release models were developed based on the experimental results.</abstract><cop>Bradford</cop><pub>Emerald Group Publishing Limited</pub><doi>10.1108/13552540810907965</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-2546 |
ispartof | Rapid prototyping journal, 2008-01, Vol.14 (5), p.293-299 |
issn | 1355-2546 1758-7670 |
language | eng |
recordid | cdi_proquest_journals_2439157041 |
source | ABI/INFORM Global; Emerald:Jisc Collections:Emerald Subject Collections HE and FE 2024-2026:Emerald Premier (reading list) |
subjects | Additives Biocompatibility Biodegradability Biodegradable materials Biomedical materials Biomedical research Composite materials Controlled release Drug delivery systems Drugs Electron microscopes Experiments Hydroxyapatite In vitro methods and tests Performance evaluation Permeability Polylactic acid Polymer matrix composites Polymers Pore size Product development Rapid prototyping Scaffolds Studies |
title | Fabrication of a biodegradable drug delivery system with controlled release made of PLGA 5-FU hydroxyapatite |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T06%3A43%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_emera&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fabrication%20of%20a%20biodegradable%20drug%20delivery%20system%20with%20controlled%20release%20made%20of%20PLGA%205-FU%20hydroxyapatite&rft.jtitle=Rapid%20prototyping%20journal&rft.au=Chu,%20Won-Shik&rft.date=2008-01-01&rft.volume=14&rft.issue=5&rft.spage=293&rft.epage=299&rft.pages=293-299&rft.issn=1355-2546&rft.eissn=1758-7670&rft.coden=RPJOFC&rft_id=info:doi/10.1108/13552540810907965&rft_dat=%3Cproquest_emera%3E2439157041%3C/proquest_emera%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c450t-d50d41023abfac305afe8a070e97069526d60bff6ece9dc6c1e215697ed18e293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=214010481&rft_id=info:pmid/&rfr_iscdi=true |